Page last updated: 2024-11-03

riluzole and B16 Melanoma

riluzole has been researched along with B16 Melanoma in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biechele, TL1
Camp, ND1
Fass, DM1
Kulikauskas, RM1
Robin, NC1
White, BD1
Taraska, CM1
Moore, EC1
Muster, J1
Karmacharya, R1
Haggarty, SJ1
Chien, AJ1
Moon, RT1

Other Studies

1 other study available for riluzole and B16 Melanoma

ArticleYear
Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanoma.
    Chemistry & biology, 2010, Nov-24, Volume: 17, Issue:11

    Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Proliferation; Gene Expression Regulation; Genes,

2010